AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 121 min read

Weekly Recap: BASF €10.3bn bid rejected and NRW backs Evonik jobs&independence

Evonik Industries AG (EVK) rejected BASF's €10.3bn takeover bid, calling it undervalued. North Rhine-Westphalia, linked to Evonik's largest shareholder, demanded job and independence protections in any deal.

Original reporting
tradingview.com
Published Oct 12, 2026, 5:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 5:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Weekly Recap: BASF €10.3bn bid rejected and NRW backs Evonik jobs&independence — source image
Source · tradingview.com
Decision brief

The 30-second read

High
01

Why it matters

The failed deal removes a potential premium for Evonik and may dampen BASF's strategic outlook.

02

Market read

Primary M&A news with significant valuation impact for both parties.

03

What to watch

Regulatory scrutiny or political pressure in North Rhine-Westphalia may have influenced the decision.

Relevance 9/10Novelty 9/10Timing: today

Background

The article reports the first public disclosure of Evonik's rejection of BASF's takeover bid.

Market effects

Sector

German chemicals sector may see heightened scrutiny of M&A activity.

Regional

European markets could react to the stalled consolidation in chemicals.

Global

Limited to chemicals sector; no broad market impact.

Counterpoint

What could challenge this read

The rejection could be a catalyst for Evonik to pursue independent growth, potentially boosting its stock.

Key entities

  • company
    Evonik Industries AG

    German chemicals producer that rejected the bid.

  • company
    BASF SE

    German chemicals giant that made the €10.3bn offer.

Read at source← All news

Related articles

OCT 9
Med

Why is Evonik Industries stock climbing today?

Evonik Industries AG stock rose nearly 2% to €21.38, hitting a 52-week high of €21.54, amid speculation of a higher bid from BASF. The RAG-Stiftung, Evonik's majority stakeholder, scheduled a meeting to discuss BASF's proposal, valued at roughly €10.3 billion. Analysts upgraded Evonik to 'Hold' with a €20 price target, citing BASF's interest as a price floor. The stock's rise occurred despite a challenging broader market environment.

investing.com2 min
SEP 28
$EVKIFHighAI 9/10

Evonik Industries Reportedly Rejects BASF's Acquisition Offer

Evonik Industries AG (EVKIF.PK) rejected a 10.3 billion euro acquisition offer from BASF SE (BAS.DE) as it was deemed too low. BASF offered 22.15 euros per share, valuing Evonik at 14.2 billion euros. Evonik's market cap is 8.4 billion euros, and its enterprise value is around 12 billion euros. Combined revenues of both companies were 74 billion euros last year. Evonik's shares were down 1.28 percent on the Frankfurt Exchange.

rttnews.com2 min
SEP 25
HighAI 9/10

Why is Evonik Industries stock surging today?

Evonik Industries' stock surged 8.1% to €19.54 after BASF SE reportedly proposed a merger, aiming to create a €74B European chemicals giant. Evonik's valuation is €12B including debt. The move follows Evonik's recent struggles, including a 52-week low of €12.49. BASF's approach is part of its strategy to streamline operations and focus on higher-margin businesses.

investing.com2 min
SEP 22
Med

Why is Evonik Industries stock rallying today?

Evonik Industries' stock rose 2.8% to €17.73 after announcing a transformation plan to cut 3,200 jobs by 2029, reorganize its portfolio, and explore investments in Asia and the Americas. The company also plans to divest two units, Syneqt and Oxeno, and will avoid compulsory redundancies. This follows a recent downgrade by Morgan Stanley.

investing.com2 min